1. Home
  2. MDXG vs OBK Comparison

MDXG vs OBK Comparison

Compare MDXG & OBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • OBK
  • Stock Information
  • Founded
  • MDXG 2006
  • OBK 1912
  • Country
  • MDXG United States
  • OBK United States
  • Employees
  • MDXG N/A
  • OBK N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • OBK Major Banks
  • Sector
  • MDXG Health Care
  • OBK Finance
  • Exchange
  • MDXG Nasdaq
  • OBK Nasdaq
  • Market Cap
  • MDXG 1.0B
  • OBK 1.0B
  • IPO Year
  • MDXG N/A
  • OBK 2018
  • Fundamental
  • Price
  • MDXG $6.77
  • OBK $33.40
  • Analyst Decision
  • MDXG Buy
  • OBK Buy
  • Analyst Count
  • MDXG 1
  • OBK 7
  • Target Price
  • MDXG $12.00
  • OBK $43.00
  • AVG Volume (30 Days)
  • MDXG 619.7K
  • OBK 147.9K
  • Earning Date
  • MDXG 10-29-2025
  • OBK 10-22-2025
  • Dividend Yield
  • MDXG N/A
  • OBK 1.80%
  • EPS Growth
  • MDXG N/A
  • OBK N/A
  • EPS
  • MDXG 0.21
  • OBK 1.91
  • Revenue
  • MDXG $363,774,000.00
  • OBK $327,688,000.00
  • Revenue This Year
  • MDXG $12.68
  • OBK $12.91
  • Revenue Next Year
  • MDXG $8.18
  • OBK $7.10
  • P/E Ratio
  • MDXG $32.20
  • OBK $17.47
  • Revenue Growth
  • MDXG 6.85
  • OBK N/A
  • 52 Week Low
  • MDXG $5.64
  • OBK $28.80
  • 52 Week High
  • MDXG $10.14
  • OBK $41.17
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 46.80
  • OBK 43.04
  • Support Level
  • MDXG $6.58
  • OBK $32.81
  • Resistance Level
  • MDXG $6.86
  • OBK $34.88
  • Average True Range (ATR)
  • MDXG 0.20
  • OBK 0.99
  • MACD
  • MDXG -0.01
  • OBK 0.05
  • Stochastic Oscillator
  • MDXG 36.17
  • OBK 38.35

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About OBK Origin Bancorp Inc.

Origin Bancorp Inc is a financial holding company. The bank provides a broad range of financial services to businesses, municipalities, high-net-worth individuals, and retail clients. The bank principally operates in one business segment, community banking. The bank is engaged in attracting deposits from individuals and businesses and using these deposits and borrowed funds to originate commercial, residential mortgage, construction, and consumer loans. The bank generates the majority of its revenue from interest earned on loans and investments, service charges, and fees on deposit accounts.

Share on Social Networks: